Latest / The BioHub - by Avetix
Episode 104 - Amir Hefni - CEO of Resolution Therapeutics
On this episode we feature the CEO of Resolution Therapeutics, Amir Hefni. Throughout his career, Amir has held roles with global powerhouses such as BMS, Ipsen, & Novartis, before transitioning to small biotech with Resolution in 2023.
Resolution's pipeline of regenerative macrophage therapies originates from research out of Edinburgh University. With potential across inflammatory & fibrotic diseases, the team are currently focused on patients with end-stage liver cirrhosis who otherwise only have transplantation as a treatment option.
Tune in to hear more about Resolution's ongoing ph1/2…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.